Short Interest in Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Declines By 17.7%

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a significant decline in short interest in June. As of June 15th, there was short interest totalling 469,900 shares, a decline of 17.7% from the May 31st total of 571,000 shares. Based on an average daily volume of 6,600 shares, the short-interest ratio is presently 71.2 days.

Kyowa Kirin Stock Performance

KYKOF stock remained flat at $17.25 during trading on Tuesday. The company’s fifty day moving average is $17.10 and its two-hundred day moving average is $17.22. Kyowa Kirin has a 1-year low of $15.78 and a 1-year high of $20.31.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.